This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Murphy C , Anderson PR , Li T , Bleicher RJ , Sigurdson ER , Goldstein LJ , Swaby R , Denlinger C , Dushkin H , Nicolaou N , Freedman GM
Impact of the radiation boost on outcomes after breast-conserving surgery and radiation
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1) :69-76
PMID: 20732766 PMCID: PMC2992091 URL: https://www.ncbi.nlm.nih.gov/pubmed/20732766
AbstractPURPOSE: We examined the impact of radiation tumor bed boost parameters in early-stage breast cancer on local control and cosmetic outcomes. METHODS AND MATERIALS: A total of 3,186 women underwent postlumpectomy whole-breast radiation with a tumor bed boost for Tis to T2 breast cancer from 1970 to 2008. Boost parameters analyzed included size, energy, dose, and technique. Endpoints were local control, cosmesis, and fibrosis. The Kaplan-Meier method was used to estimate actuarial incidence, and a Cox proportional hazard model was used to determine independent predictors of outcomes on multivariate analysis (MVA). The median follow-up was 78 months (range, 1-305 months). RESULTS: The crude cosmetic results were excellent in 54%, good in 41%, and fair/poor in 5% of patients. The 10-year estimate of an excellent cosmesis was 66%. On MVA, independent predictors for excellent cosmesis were use of electron boost, lower electron energy, adjuvant systemic therapy, and whole-breast IMRT. Fibrosis was reported in 8.4% of patients. The actuarial incidence of fibrosis was 11% at 5 years and 17% at 10 years. On MVA, independent predictors of fibrosis were larger cup size and higher boost energy. The 10-year actuarial local failure was 6.3%. There was no significant difference in local control by boost method, cut-out size, dose, or energy. CONCLUSIONS: Likelihood of excellent cosmesis or fibrosis are associated with boost technique, electron energy, and cup size. However, because of high local control and rare incidence of fair/poor cosmesis with a boost, the anatomy of the patient and tumor cavity should ultimately determine the necessary boost parameters.
NotesMurphy, Colin Anderson, Penny R Li, Tianyu Bleicher, Richard J Sigurdson, Elin R Goldstein, Lori J Swaby, Ramona Denlinger, Crystal Dushkin, Holly Nicolaou, Nicos Freedman, Gary M eng P30 CA006927/CA/NCI NIH HHS/ P30 CA006927-47S5/CA/NCI NIH HHS/ Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):69-76. doi: 10.1016/j.ijrobp.2010.04.067. Epub 2010 Aug 21.